
For weight loss, diet may matter more than exercise

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Independent
an hour ago
- The Independent
What is chikungunya? Symptoms and travel advice as cases rise in France
Health authorities are warning travellers of a mosquito-borne virus that can cause debilitating joint pain, after cases emerged in areas of France. While the virus known as chikungunya is more commonly found in tropical areas of the world, cases have now appeared in France, a popular holiday destination for Brits, especially during the summer months. The World Health Organisation has now raised its concern about the virus, giving new guidelines to healthcare providers on how to help those who have contracted chikungunya. Diana Rojas Alvarez, a medical officer at the WHO, told reporters in Geneva that an estimated 5.6 billion people live in areas across 119 countries at risk from the virus. This year so far, France has reported 30 cases of chikungunya virus on the mainland and the French island of Corsica. Italy has reported one. While Europe is not currently experiencing a severe outbreak, health officials on the continent are making travellers aware of the virus as well as the rollout of a new vaccine in the UK. We have rounded up what travellers need to know about the virus, plus advice from a specialist travel doctor on how to best prepare for travelling overseas. What is chikungunya and how is it spread? Chikungunya virus disease is a mosquito-borne disease that is found across tropical and sub-tropical regions. It is spread to humans by a bite from an infected mosquito. It cannot be passed from human to human. Most cases have been found in the Americas, Africa and Asia. Brazil has the most cases, with over 141,000, followed by Argentina with over 2,500 so far in 2025. In total, there have been approximately 220,000 chikungunya cases and 80 related deaths across 14 countries/territories since the beginning of the year. La Réunion and Mayotte, two French islands off the east coast of Africa, have ongoing outbreaks of chikungunya, with the former recording 51,000 cases as of May 2025. The transmission of dengue and chikungunya virus in mainland Europe has been linked by the European Centre for Disease Prevention and Control (ECDC) to travellers who have caught the virus outside the region, then gone to countries within Europe with mosquitoes that are able to carry the virus after biting the person. 'The risk of locally acquired chikungunya and dengue virus transmissions is therefore increasing,' the ECDC said. What are the symptoms? 'Chikungunya' comes from a word used by the Makonde people in Tanzania, where the disease was first discovered in the 1950s, which means 'that which bends up'. This describes the contorted posture of infected people who experience severe joint pain. Alongside joint pain, people can also experience an abrupt onset of fever, joint swelling, muscle pain, headaches, nausea, fatigue and rashes. The joint pain can be debilitating and usually lasts for a few days, but it has been known to last for weeks, months or even years. If an infected person does not experience joint pain, the symptoms will be mild and can go unrecognised as chikungunya. Most people will recover fully from the infection. There have been some occasional cases of eye, heart, and neurological complications, while newborns and older people with underlying medical conditions are at a higher risk of severe disease. Patients with severe disease should be hospitalised because of the risk of organ damage or death. Once someone has recovered from chikungunya, they are likely to be immune to future chikungunya infections. Is there a vaccine? The UK government has approved vaccines against chikungunya disease, containing a form of the virus that has been weakened so it cannot multiply. The vaccine works by training the immune system to recognise the virus, which will then produce specific antibodies to attack it. It can only be obtained via a prescription and given to those who plan to travel abroad where the virus is present. Last month, the government released a further announcement to say that the Commission on Human Medicines has temporarily restricted the use of the vaccine in people aged 65 and over as a precautionary measure. To prevent getting bitten by mosquitoes, the World Health Organisation advises using insecticides; wearing clothing that minimises skin exposure; using window and door screens, and insecticide-treated mosquito nets; and applying certain repellants to skin and clothing. A travel doctor's guide on being prepared Dr Richard Dawood, a travel medical specialist at Fleet Street Clinic, explained to The Independent how the vaccination can help travellers prevent getting sick from the chikungunya virus. He said: 'This is a new situation for us. Until a very short time ago, we had no vaccine, and the only approach to prevention was to make careful use of insect repellents and insect precautions. 'So now we've got this extra tool in the armoury, and because the vaccine gives long-lasting protection, it's something that could be considered if you are planning to travel over a period of time. 'It's a fairly expensive vaccine, but if you're going to be travelling over a period of years to Southern Europe and beyond, it may be something that could be considered.' When asked about getting the vaccination for a trip to France, Mr Dawood advised to look at the decision in terms of where you will be travelling over the next few years rather than in the context of a single trip. 'The risk from a one-off short trip to France is probably very small,' he said. 'There's been only a very small number of cases so far. So statistically, you're not very likely to, but over time, as somebody who loves to travel and loves going to hot countries, then I would probably want to be protected against it in the long term.' Wherever you are travelling, Mr Dawood advised holidaymakers to 'do your homework'. He said: 'If there's an actual outbreak at your destination, then I would say no hesitation, definitely have the vaccine. 'Taking a bit of time and getting some really focused travel health advice for your particular trip is very worthwhile because it can save you from getting a vaccine that you don't need or that may not be sensible for you, and it can help prioritise the really important things for your trip.


Reuters
an hour ago
- Reuters
Hospitals in Syria's Sweida struggling after sectarian clashes, WHO says
GENEVA, July 25 (Reuters) - The main hospital in the southern Syrian city of Sweida is overwhelmed with trauma patients and working without adequate power or water after the local Druze minority clashed almost two weeks ago with Bedouin and government forces. "Inside of Sweida, it's a grim picture, with the health facilities under immense strain," the World Health Organization's Christina Bethke told reporters in Geneva via video link from Damascus. "Electricity and water are cut off, and essential medicine supplies are running out." Many medical staff cannot reach their workplace safely, and the main hospital's morgue was full at one point this week as it dealt with a surge of trauma cases. At least 903 people were killed in the sectarian bloodshed, according to the Syrian Network for Human Rights, after clashes between Druze militias and Bedouin tribes spilled into ferocious fighting between the Druze and government forces sent to quell the unrest. The Network's head, Fadel Abdulghany, has said the toll is not final, and that his group documented field executions by Syrian troops, Bedouin tribal fighters and Druze factions. Though the WHO has managed to deliver two convoys of aid in the last week, access remains difficult because tensions remain between the groups controlling various parts of Sweida governorate, it said. More than 145,000 people have been displaced by the recent fighting, the WHO said, with many sheltering in makeshift reception centres in Daraa and Damascus.


Telegraph
2 hours ago
- Telegraph
Poor regulation causing hundreds of deaths from contaminated medicines globally, says WHO report
Weak regulation has allowed children's medicines like cough syrup and paracetamol to be laced with toxic industrial chemicals leading to hundreds of deaths, according to a report by the World Health Organization. Since 2022, at least 300 people – mainly children in Africa and Asia – have died from cough and paracetamol syrups containing diethylene glycol (DEG) and ethylene glycol (EG): industrial chemicals that are used to make products like brake fluid and antifreeze. The chemicals – a cheap replacement for medicinal glycol – are toxic in even small amounts and cause acute kidney damage that often proves fatal. The WHO report, released jointly with the United Nations Office on Drugs and Crime, said 'criminal networks' were exploiting 'market volatility and regulatory gaps' to introduce these and other toxins into the supply chain in order to make quick profits. 'Most of the recent cases involve inexpensive oral liquid medicines that can be bought without a prescription,' said the report. 'In most cases these medicines were marketed specifically for children and are … available in pharmacies, medicine stores or informal street markets.' In 2022, more than 150 children died in Indonesia from consuming locally produced cough syrups that had been laced with EG. The manufacturer had marked 60,000 bottles of the lethal medication with fake labels showing only safe ingredients, the report said. In the same year, at least 66 children, mostly under the age of two, died in the Gambia from acute kidney failure after consuming cough syrup containing DEG and EG, imported from India. The medicines were produced by the Indian manufacturer, Maiden Pharmaceuticals, which was later discovered to have breached numerous regulations. Two of the owners of the company received prison sentences, the report said. Over the last three years, at least five batches of lethal cough syrups have been traced back to Indian manufacturers from countries including Uzbekistan, Cameroon, and Iraq. Some were found to contain over 20 times the safe level of EG . Each contaminated medicine was produced by a different manufacturer, raising questions about the regulation of India's pharmaceutical industry. Overall, the World Health Organization said at least 1,300 people have died as a direct cause of ingesting contaminated medicines over the last 90 years, and thousands more have suffered 'life changing injuries' – mostly in the developing world. 'In many cases, contaminated medicines are the result of intentional criminal conduct. Addressing this threat requires coordinated efforts by ... law enforcement agencies, customs officials, prosecutors and anti-corruption bodies,' the report said.